Janssen Pharmaceutica NV

Janssen Pharmaceutica NV is a Belgium-based pharmaceutical company that forms part of Johnson & Johnson. Founded by Dr. Paul Janssen, the company became part of Johnson & Johnson in 1961 and has played a major role in the group's pharmaceutical research and development activities. The wider Janssen pharmaceutical business was rebranded as Johnson & Johnson Innovative Medicine in 2023. Janssen Pharmaceutica NV remains a legal entity based in Beerse, Belgium, and participates in pharmaceutical research and European collaborative innovation projects. It coordinates the Horizon Europe-funded DiCE project on circular digital health devices.